Prenatal Immune Challenge Is an Environmental Risk Factor for Brain and Behavior Change Relevant to Schizophrenia: Evidence from MRI in a Mouse Model by Li, Qi et al.
Prenatal Immune Challenge Is an Environmental Risk
Factor for Brain and Behavior Change Relevant to
Schizophrenia: Evidence from MRI in a Mouse Model
Qi Li
1,2., Charlton Cheung
1., Ran Wei
1, Edward S. Hui
3, Joram Feldon
4, Urs Meyer
4, Sookja Chung
5,
Siew E. Chua
1,2,6, Pak C. Sham
1,2,6,E dX .W u
3, Grainne M. McAlonan
1,2,6*
1Department of Psychiatry, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (S.A.R.), China, 2Centre for Reproduction Growth and
Development, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (S.A.R.), China, 3Laboratory for Biomedical Imaging and Signal Processing,
University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (S.A.R.), China, 4Laboratory of Behavioural Neurobiology, Swiss Federal Institute of
Technology Zurich (ETH), Schwerzenbach, Switzerland, 5Department of Anatomy, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (S.A.R.),
China, 6State Key Laboratory for Brain and Cognitive Sciences, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (S.A.R.), China
Abstract
Objectives: Maternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia
and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged
lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal
infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal
immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood.
Method: We used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered
in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the
whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles.
Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities.
Results: PolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles
in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in
the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4
th
ventricle volume but did not disrupt sensorimotor gating.
Conclusions: Our results provide the first experimental evidence that prenatal immune activation is an environmental risk
factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental
insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in
late prenatal life.
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Introduction
The aetiology of complex neurodevelopmental brain disorders
such as schizophrenia and autism is unknown. Epidemiological
evidence strongly suggests that maternal infection during prenatal
life maycontributetoanincreased riskofschizophrenia orautism in
the offspring [1–7] and exposure to prenatal infection has been
recently linked to specific neuropathological changes in schizophre-
nia [8]. A causal relationship in this epidemiological link has
received considerable support from several experimental models of
prenatal infection and/or immune activation. A multitude of
behavioural, cognitive and pharmacological abnormalities has been
detected in adult mice and rats following prenatal or neonatal
exposure to viral pathogens [9–15], the viral mimic polyriboino-
sinic–polyribocytidilic acid (PolyI:C) [16–22], the bacterial endo-
toxin lipopolysaccharide (LPS) [23,24] and the pro-inflammatory
cytokine interleukin (IL)-6 [25,26]. The most prevalent hypothesis
suggests that infection-induced disruption of prenatal or early
postnatal brain development predispose the offspring to long-lasting
changes in subsequent brain and behavioural development and
ultimately leads to adult neuropathology and associated behavioural
changes in adolescence or early adulthood [25,27].
Schizophrenia is associated with significant, progressive brain
morphological changes which become evident by early adulthood
[28]. Ventricular enlargement is the most consistently replicated
finding in patients with schizophrenia [29] and is already present
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psychotic medication [30]. Cannon and colleagues [31] found that
ventricular enlargement and associated reductions in white matter
and subcortical volumes were unique to the clinical phenotype of
schizophrenia. That is, ventricular enlargement in patients is
thought to be due to primary causative factors not shared by
relatives with some shared genetic risk. Genetic model fitting on
twin and sibling data indicates that ventricular enlargement in
schizophrenia is driven by individual-specific environmental
influences [32] and patients with largest ventricles have also been
shown to have poor prognosis [33,34]. Considering the known
impact of prenatal infection on schizophrenia risk, the specificity of
ventriculomegaly to the clinical illness and the suggested
environmental influences on ventricular enlargement in this
disorder, maternal infection during pregnancy may represent a
significant environmental risk factor of ventricular enlargement in
the offspring. However, direct evidence for this hypothesis is still
missing. Examination of prenatal immune activation effects on
ventricular abnormalities and associated schizophrenia-related
dysfunctions in adult life is clearly warranted.
Therefore, the present study was designed to test the hypothesis
that there is a causal relationship between prenatal immune
challenge and changes in ventricular size in the adult offspring.
We used a well established mouse model of maternal immune
activation (MIA) by the viral mimic PolyI:C, which induces a
cytokine-associated viral-like acute phase response in mammalian
organisms [35]. Prenatal PolyI:C exposure in mice and rats is known
to induce a wide spectrum of brain and behavioral dysfunctions
implicated in schizophrenia and/or autism (for a review see [36]).
Interestingly, recent experimental investigations using the PolyI:C
model of MIA have highlighted that the precise timing of MIA is a
critical determinant of the specificity of the long-term brain and
behavioral pathology emerging in the offspring [36–38]. This
parallels the human epidemiological findings that the strength of the
association between prenatal infection and adult psychotic disorders
appears to be critically influenced by the precise timing during
prenatal life. In contrast to the data obtained by initial retrospective
epidemiological research designs [39–42], recent epidemiological
studies using serologic markers of maternal infection suggest that
infections during the early stages of pregnancy (i.e. in the first
trimester of human pregnancy) have a stronger impact on
schizophrenia risk in the offspring compared to second or third
trimester infections [1,43–45]. However, it is unknown whether a
postulated neurodevelopmental impact of early versus middle/late
prenatal infections on ventricular abnormalities in later life would
show a similar temporal dependency.
In order to directly address this issue, we compared the effects of
MIA in early (gestation day [GD] 9) and late (GD17) gestation on
ventricular abnormalities in the offspring. We adopted an in-vivo
volumetric magnetic resonance imaging (MRI) approach to help
surmount some of the difficulties associated with ex-vivo analyses.
For example, ex-vivo analyses using perfusion-fixation can chem-
ically alter intracellular and extracellular fluid dimensions and
subsequent histological processing causes tissue dehydration and
mechanical deformation [46]. The in-vivo method also has the
advantage of allowing further live testing of the animal after
scanning [47,48]. Here, we used 2 complementary MRI analyses
methods. First we describe the application of automated voxel-
based morphometry (VBM) to map the volume of cerebrospinal
fluid (CSF) across the whole brain. VBM relies on intensity based-
segmentation of brain into distinct tissue classes (namely, grey
matter, white matter and CSF) creating tissue class maps for
independent, rapid, and exploratory analysis of every volume-
element of brain. Recently, VBM has been applied to the ex-vivo
study of a mouse model of Huntington’s disease [49]. In the
present study we propose rapid in-vivo scanning for VBM analysis
of CSF volume in the MIA mouse model, using segmentation
techniques that do not require priori information but instead use
manual region-of-interest (ROI) tracing of the lateral ventricles to
confirm VBM findings. We predicted that, in addition to the
behavioural phenotype, early MIA would be ‘worse’ than later
MIA in terms of gross brain anatomical disruption leading to
ventricular enlargement.
Results
Early but not late prenatal immune challenge leads to
enlarged lateral ventricles in adulthood
The volumetric analyses of in-vivo MRI data showed that
prenatal immune activation in early (GD9) or late (GD17)
gestation did not significantly change total brain volume
(F(2,19)=.162, p,.851), grey matter (F(2,19)=.017, p,.98) or white
matter volume (F(2,19)=.136, p,.87) relative to prenatal control
treatment. However, the application of VBM to map the volume
of CSF showed greater CSF volumes in the lateral ventricles of
offspring exposed to MIA on GD9 compared to control offspring
(Figure 1). Importantly, the impact of prenatal immune challenge
on CSF volumes in the lateral ventricles was clearly restricted to
MIA in early gestation because no significant changes in lateral
ventricular CSF volumes were apparent in offspring exposed to
MIA in late gestation (i.e., on GD17) relative to controls
(Figure 1). Instead VBM indicated an expansion in 4
th ventricle
volume in offspring exposed to prenatal challenge in late gestation.
ANOVA of region of interest measures supported this effect of
prenatal treatment on lateral ventricle volume (F(2,19)=5.39,
p,.01) and subsequent post-hoc analyses confirmed lateral
ventriculomegaly in offspring exposed to MIA on GD9 relative
to control offspring (see Tables 1, 2 and Figure 1).
Early but not late prenatal immune challenge disrupts
sensorimotor gating in adulthood
In this test, a reduction of startle reactivity to the pulse stimulus
on prepulse-plus-pulse trials relative to pulse-alone trials consti-
tutes the PPI effect. The analysis of percent PPI (% PPI) confirmed
that offspring exposed to MIA on GD9 but not on GD17 displayed
reduced sensorimotor gating relative to control offspring
(Figure 2). A 36363 (group6prepulse intensity6pulse intensity)
repeated measures ANOVA showed a significant effect of prepulse
intensity [F(2, 131)=11.87, p,0.0001] and a significant group
difference in %PPI [F(2, 131)=3.56, p,0.05]. There was also a
significant interaction between pulse intensity and group [F(4,
262)=4.32, p,0.01]. Subsequent post-hoc tests verified that the
overall group difference in %PPI was driven by a significant
impairment in PPI in the GD9 PolyI:C compared to control group
(p,0.05). This PPI deficit in GD9 PolyI:C animals was evident in
the pulse 100 and pulse 120 conditions (p,0.05). There was no
difference in %PPI between GD17 PolyI:C and control groups
(Figure 2). There were no significant group differences in startle
reactivity, startle habituation or prepulse-elicited reactivity (data
not shown). Hence, the PPI attenuating effects of prenatal PolyI:C
exposure in early gestation cannot be accounted for by changes in
general startle reactivity and/or prepulse detection, reflecting a
genuine disruption of sensorimotor gating.
Discussion
The present study provides the first piece of evidence supporting
the hypothesis that prenatal immune activation may be a relevant
Prenatal Risk in Schizophrenia
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hood. Using an experimental model of MIA by the viral mimic
PolyI:C, our results demonstrate a casual relationship between
maternal exposure to a viral-like acute phase response during early
gestation and the subsequent emergence of enlarged lateral
ventricles in the adult offspring. Importantly, this relationship
appears to be clearly restricted to prenatal immunological insults
taking place during early foetal development. This is because no
Table 1. Mean volumes of lateral ventricles and tissue compartments.
Group Grey White G/W Total Brain Volume Left Ventricle Right Ventricle L/WBV R/WBV
(mm
3)( m m
3)( m m
3)( m m
3)( m m
3)
Control 188.3615.0 127.0612.8 1.50 330.469.9 2.446.24 2.436.28 0.0074 0.0074
GD9 189.7616.1 124.9610.5 1.54 328.668.4 2.756.46 2.806.37* 0.0084 0.0085 {
GD17 188.9614.7 128.1612.6 1.49 331.166.3 2.386.38 2.256.32 0.0072 0.0068
Main tissue compartment volumes and lateral ventricular volumes6Standard Deviation are shown. G/W, ratio of total grey matter to white matter tissue volumes; L/
WBV, ratio of left ventricle region-of-interest volume to whole brain volume; R/WBV ratio of right ventricle region-of-interest to whole brain volume.
*Significant difference of Right Ventricle between GD9 and controls (p,.036 two-tailed).
{Significant difference of R/WBV between GD9 and controls (p,.047 two-tailed).
doi:10.1371/journal.pone.0006354.t001
Figure 1. CSF space quantified using VBM and ROI methodology. a. Overlap in lateral ventricles quantified using voxel-based morphometry
(VBM) and region-of-interest (ROI) methodology showing an animal with the lowest agreement (Dice=0.92 both sides) between the manual
delineation and automatic segmentation of ventricles. Left ventricle in grey; right ventricle in white. b. Region-of-Interest defined lateral ventricles.
Raw images and the 3D rendered lateral ventricles of a mouse from the control and one from the GD9 group. c. Voxel-wise analyses of CSF in adult
mice exposed to prenatal challenge at GD9 compared to control and GD17 compared to control. Red indicates a significantly greater likelihood of
finding CSF; Blue indicates a significantly lower likelihood of finding CSF.
doi:10.1371/journal.pone.0006354.g001
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offspring exposed to MIA in late gestation (Figure 1). Hence,
prenatal immune challenge in early gestation has a greater impact
on the development of lateral ventricular abnormalities compared
with immune activation at late stages of pregnancy. Our parallel
behavioral analysis further confirmed that MIA in early gestation
leads to a wider spectrum of schizophrenia-related abnormalities
in the adult offspring compared to identical MIA in late gestation:
Adult mice prenatally exposed to PolyI:C on GD9 displayed PPI
deficits whereas offspring subjected to PolyI:C exposure on GD17
did not. Together, our findings support the hypothesis that early
prenatal immune activation in general, and exposure to a viral-like
acute phase response in particular, exert a more extensive
neurodevelopmental impact in terms of schizophrenia-related
brain and behavioral abnormalities compared with immunological
insults taking place later in gestation.
The early and late gestational windows selected in the present
study (i.e., GD9 and GD17 in the mouse) correspond roughly to
the middle of the first and second trimester of human pregnancy
respectively [50]. Hence, when extrapolating the present findings
to human epidemiological data, our results corroborate recent
epidemiological studies using serologic verification of the maternal
infection to suggest that infections during the early stages of
pregnancy (i.e. in the first trimester of human pregnancy) are
associated with the highest risk of schizophrenia and related
disorders [1,3,43–45,51]. We acknowledge that prenatal immune
activation is not the only possible cause of ventricular enlargement,
and other rodent models of schizophrenia have shown ventricular
enlargement [52]. However, we believe the present experiments
do highlight the importance of immune exposure in what is a
multifactorial and complex condition. A clear relationship between
prenatal infection and risk of ventricular enlargement in
schizophrenia has not been established yet in human literature.
The present experimental findings may therefore serve to
encourage further exploration of possible infectious aetiologies of
ventricular abnormalities in schizophrenia and related disorders.
In an elegant study fractionating the contribution of individual
cytokines to the behavioural phenotype following MIA, Smith and
co-workers [26] found IL6 was a key trigger to neurodevelop-
mental disruption. In addition to its role in inflammation, IL6
activates the JAK-STAT signal cascade which has an important
role in embryonic development, neurogenesis and gliogenesis
[53,54]. Interestingly, the IL6 receptor is highly expressed in the
ganglionic eminence (GE) of the germinal cells lining the
ventricles. This germinal layer gives rise to neurons and glia
during early and mid fetal life and the GE component contains the
precursor cells of the striatum and lasts much longer than other
proliferative zones of the embryonic brain [55]. It is therefore
postulated that activation of the IL6-R of the immature cells of the
Table 2. Voxel-wise comparison of GD9 and GD17 MIA mice with controls.
Location Cluster Size (mm
3) Z score p value Co-ordinates (mm)
XY Z
GD9.Control
Left Lateral Ventricle 0.37 3.11 .001 20.88 20.48 22.64
Right Lateral Ventricle 0.18 2.84 .002 0.96 20.96 21.84
Control.GD9
Third Ventricle 0.22 3.73 .000 0.00 20.32 23.12
Cerebral Aqueduct 0.13 3.04 .001 20.08 24.96 22.8
Fourth Ventricle 0.26 2.95 .002 20.24 25.92 24.08
Third Ventricle 0.08 2.85 .002 20.08 21.44 26.32
GD17.Control
Fourth Ventricle 0.33 3.39 .000 0.24 26.48 23.68
Control.GD17
Right Lateral Ventricle 0.29 3.68 .000 0.8 0.72 23.6
Left Lateral Ventricle 0.10 3.07 .001 23.36 22.16 24.32
Right Lateral Ventricle 0.17 2.98 .001 1.84 21.2 21.68
X, Y, Z co-ordinates are based on the Lambda-Bregma system in the Allen mouse brain atlas. Cluster Size=0.0768 mm
3.
doi:10.1371/journal.pone.0006354.t002
Figure 2. Prepulse inhibition of startle. Behavioral tests in mouse
exposed to maternal immune activation at gestation day 9 or 17 (GD9
POL; GD17 POL) compared to controls (CON). Prepulse inhibition of
startle (PPI). % PPI= (pulse-alone - prepulse-plus-pulse)/pulse-
alone6100%. A gradual increase in the amount of inhibition was
observed as a function of the increasing intensity of the prepulse
stimulus. All values are means6SEM.
doi:10.1371/journal.pone.0006354.g002
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development and migration of neurons particularly in the
striatum, and hence impacts upon the surrounding ventricular
space. This is consistent with evidence pointing to disorder of
neuronal migration in schizophrenia [56–58], disrupted connec-
tivity in schizophrenia [59,60] and striatal and ventricular
morphological differences in schizophrenia [29,30,61,62]. Further
evidence that the germinal matrix is especially vulnerable to
inflammatory mediators comes from observations of subependy-
mal cysts at the head of the caudate following congenital rubella
infection [63]. As mentioned earlier, prenatal rubella infection is
strongly associated with schizophrenia [1] and subependymal cysts
have also been reported in children with autism who had
congenital infection [64].
Our results raise a question about the relevance of late
pregnancy MIA to neurodevelopmental disorders. At first glance
the absence of ventricular enlargement in GD17 mice appears to
shifts the specificity of this exposure away from schizophrenia at
least. However, prenatal exposure of mice to human influenza
virus on GD18 alters the expression of genes associated with
schizophrenia and autism such as Sema3a, Trfr2 and Vldlr [65]
and both GD9 and GD18 exposures cause up-regulation of the
transcription factor Foxp2 [65,66] which has been linked with
schizophrenia [67] and autism [68]. Therefore one explanation of
these findings is that the effect of MIA at GD17 is indeed simply
milder than at GD9 [36], that this exposure is sufficient to cause
some but not all of the neurodevelopmental phenotype relevant to
schizophrenia.
Another possible explanation is that the outcome of MIA on
GD17 translates to a different subtype of schizophrenia. Patients
with schizophrenia may be categorized on the basis of their
memory deficits and associated brain morphology [69]. Those
with primarily encoding/storage difficulties or ‘cortical’ pattern
deficits are in the minority and have isolated temporal lobe
pathology. The majority have a ‘subcortical’ pattern of retrieval
difficulties associated with ventricular enlargement and frontal
grey matter reductions [69]. Relevant to this discussion are our
previous results [38] showing impaired spatial working memory in
mice exposed to MIA on GD17, not GD9. Spatial working
memory depends upon intact temporal lobe circuits [70,71], thus
the GD17 mice appear to have a degree of commonality with the
‘cortical’ subgroup of patients with schizophrenia who have
‘working’ memory deficits, but no ventricular enlargement. In
contrast the GD9 group with enlarged ventricles fits the
subcortical or fronto-striatal schizophrenia phenotype described
by Turetsky and colleagues [69] or the psychotic cohort with
enlarged ventricles sampled in the study by Cannon et al [31]. A
PPI impairment restricted to the GD9 ‘ventricular enlargement’
group also fits well with the evidence that sensorimotor gating has
a strongly frontal-striatal basis [72–74]. Indeed the PPI impair-
ment in schizophrenia has recently been shown to correlate with
lower grey matter volumes in dorsolateral prefrontal, middle
frontal and the orbital/medial prefrontal cortices [75] and is
associated with activation abnormalities in fronto-striatal circuits
[72]. Unfortunately it is not known if patients with schizophrenia
categorized on the basis of memory impairment can also be
distinguished on the basis of PPI impairment, but a prediction that
this minority of ‘cortical’ patients have less PPI impairment, would
be interesting to test.
Complicating this interpretation is the issue of autism. Autism
has been suggested to lie on the same spectrum as schizophrenia
with individuals with schizotypy also having a significant number
of autistic traits [76]. People with autism spectrum have a strong
family history of schizophrenia and bipolar disorder [77] and some
children with autism go on to develop schizophrenia in later life.
People with Asperger’s syndrome have higher scores on measures
of paranoia than healthy controls [78] and ‘negative’ symptoms in
Asperger’s syndrome appear to respond to the antipsychotic
risperidone [79]. Together these overlapping observations support
the possibility that autism disorders and schizophrenia share causal
influences. Although PPI is generally thought to be disrupted in
higher functioning individuals with autism spectrum [80,81],
others have found limited evidence for sensorimotor gating
abnormalities in a broader sample of ages and abilities [82]. The
mice exposed to MIA at GD 17 without PPI deficits therefore
appear to better reflect the cohort in this latter study.
The VBM analysis generated an unpredicted effect of late MIA
on 4
th ventricle volume. This would not have been identified from
a ROI analysis alone and highlights the advantage of a whole-
brain analytic method in uncovering unexpected, fresh informa-
tion. What exactly 4
th ventricular enlargement following late MIA
means will be important to explore. An adjacent loss of regional
cerebellar volume might contribute to this result and discrete
regions of the cerebellar vermis have been reported to be smaller
in schizophrenia despite no overall difference in cerebellar volume
[83]. The evidence for cerebellar abnormalities in autism spectrum
is extensive and convincing [84–88], and changes are likely to be
progressive [89,90]. Potentially the timing of a prenatal event,
either genetic or environmental or indeed epigenetic, critically
influences phenotypic outcome along a schizophrenia-autism
spectrum in later life. Our future work will focus on validating
the segmentation of other tissue class compartments segmented in
VBM in order to map the full impact of prenatal immune
challenge at different time points on brain structure and its
relevance to specific neurodevelopmental disorders.
The in-vivo scanning design adopted in our study offered a
number of other advantages. It meant that behaviour and brain
structure could be characterized in the same cohort of animals.
However, since the behaviour testing could potentially modulate
brain and the procedures involved in MRI, including prolonged
anesthetic exposure, might influence behaviour testing, we
conducted the PPI study in animals with and without MRI. In
addition, we avoided confounding effects of fixation and histology
approaches on ventricular morphometry with in-vivo MRI. The
novel application of VBM methods to map the in-vivo CSF space in
the mouse was validated using manual ROI measurement of the
lateral ventricles and we believe the in-vivo technique holds
particular promise for the study of longitudinal changes during
evolution of the disease process. Conventional anti-psychotic and
anti-depressant drug treatment prevents the behavioural impact of
early MIA [91] and we are now looking at whether ventricular
enlargement can also be halted by drug treatment. The VBM
analysis methods adopted here add to the potential for rapid
throughput of such studies.
A disadvantage of our study is that resource constraints meant
that the numbers included were modest, but supplementing the
VBM approach with a manual ROI quantification of ventricular
volume lends considerable confidence that the effects seen are
robust. Lastly, we included only male animals in our study and we
cannot say for certain that the results can be extrapolated to
females. There is good evidence that ventricular enlargement in
schizophrenia is actually greater in females than males with the
condition [92] and, as the MIA behavioural phenotype is observed
in both male and female offspring [38], we think it is likely that
similar ventricular enlargement would be present in the female
offspring. Future studies will address the issue of gender.
In conclusion, we show dramatic differences in brain ventricular
morphometry in mice exposed to a brief, non-specific immune
Prenatal Risk in Schizophrenia
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exposure the poorer the outcome in terms of both behaviour and
brainmorphometry.Thecurrentexperimentsdonottelluswhether
the ventricular changes observed are caused directly or indirectly.
We suspect they may be an indirect consequence of regional
changes in periventricular structures and our on-going studies will
explore this in detail. Thus our work provides strong impetus for
further investigation of the role of prenatal immune mechanisms in
the pathogenesis of schizophrenia and related disorders because
such effects are potentially modifiable. It encourages the application
ofcomplementaryimagingand behaviouraltechniquestosearchfor
causal mechanisms and new treatments in these poorly understood
neurodevelopmental disorders.
Materials and Methods
Animals
Female and male C57BL6/N were bred and mated by The
University of Hong Kong, Laboratory Animal Unit, (LAU).
Timed-pregnant mice were held in a 12:12 h reversed light-dark
cycle (lights on at 19:00), and temperature and humidity-
controlled (2161uC, 5565%) animal vivarium. Animals were
maintained under ad libitum food and water diet supplied by the
LAU. All experiments were approved by the Committee on the
Use of Live Animals in Teaching and Research at The University
of Hong Kong and every effort was made to minimize the number
of animals used and their suffering.
Prenatal treatment
This followed the procedures previously reported [16,17,37].
PolyI:C (potassium salt) was obtained from Sigma Aldrich and
dissolved insaline. A dose of5 mg/kg in an injection volumeof 5 ml/
kg, prepared on the day of injection was administered to pregnant
dams on GD9 and GD17 via the tail vein under mild physical
constraint. Control animals were administered 5 ml/kg saline via tail
vein on either GD9 or GD17. The animals were returned to the
home cage after the injection. The resulting offspring were weaned
and sexed at postnatal day (PND) 21. The pups were weighed and
littermates of the same sex were caged separately, three to four per
cage. Male offspring only were used in the following experiments.
MRI
In-vivo MRI scanning took place at 12-weeks old in a 7 T scanner
with a maximum gradient of 360 mT/m (70/16 PharmaScan,
Bruker Biospoin GmbH, Germany). Animals were weighed before
scanning and were anesthetized during scanning with isoflurane/air
mixture at 3% for induction and 1.5% for maintenance via a nose
cone. A quadrature RF coil with 23 mm inner diameter was used. A
set of scout images [T2 – weighted: Effective TE=38.71 ms,
TR=4614.566 ms,NoofAverage=6,RareFactor=8,Acquisition
Matrix=2566256, FOV=25625 mm, Slice thickness=0.25 mm,
Scan Time=11 m4 s] in axial orientation were acquired in each
animal. This sequence took less than one hour. Preliminary analysis
indicated no difference between animals exposed to saline on GD9
(n=3) or GD17 (n=5) therefore these mice were combined in a
single control group. The final numbers in MRI study were:
controls=8, PolyI:C=14 (PolyI:C, GD9=8, GD17=6).
Region of interest (ROI) measurement
Manual measurements were done using InsightITK-Snap
(http://www.itksnap.org/) by a single rater (WR), blind to subject
group membership. Total brain volume was measured from a
mask that delineates brain tissue from the skull, generated by the
semi-automatic, region growing ‘‘3D-snake’’ method. Each of the
masks was manually edited for any miscoverage. Lateral ventricles
were delineated according to previously described boundaries and
landmarks [93]. Voxels within the region of interest were
highlighted slice-by-slice with the ‘‘Paint bush’’ tool. Left and
right lateral ventricles were labeled separately.
Voxel based Morphometry (VBM)
Images were preprocessed with SPM2 (http://www.fil.ion.ucl.
ac.uk/,spm/) and FSL (http://www.fmrib.ox.ac.uk/fsl/) running
on a Linux workstation. The whole preprocessing routine included
skull stripping, custom template creation, tissue classification and
normalization.
In the first step, the skull was removed from the raw image by
subtracting the brain mask created in the previous section. This
‘skull-stripped’ brain was transformed to a standard space by co-
registering to a publicly available mouse template [94] using a 12-
paramenter affine transformation [95] in SPM2. The normalized
brains of all the mice were averaged to create a custom template.
The skull-stripped image was segmented into corresponding
tissues classes using an intensity based tissue classification kernel [96]
in FSL. Since ‘a priori’ information on the probability distribution of
different tissue types was not available, the assignment of tissue
classes was based solely on voxel intensities. The kernel was set to
classify brain tissue into 5 compartments instead of the conventional
3 (grey, white and CSF) for a more refined classification. The extra
compartments captured whole brain grey matter comprising
cortical, and hippocampal formation grey matter, and whole brain
white matter comprising cortical (corpus callosum, internal capsule)
andpontinewhitematter.Thetissuemapsofthe2greymatterand2
white matter compartments were combined to give the more
conventional 3-class grey, white and CSF (see Figure 3).
In the last step, the skull-free brain was normalized to the
custom template using a combination of linear and non-linear
transformation [95] in SPM2. The parameters from this
transformation were applied to normalize the segmented tissue
maps from the previous step. Finally, as ventricular volumes were
the focus of the current study, the normalized CSF map was
modulated [97] and smoothed with a 0.3 mm FWHM Gaussian
kernel for analysis.
Statistical analysis was done in SPM2, using ‘‘Single-subject:
conditions & covariates’’ to compare ventriclar volume between
different groups. All results were threshold at uncorrected p,.005
(seed) and p,.05 (extension), and a minimum cluster size 150
voxels6(0.0860.0860.08) mm/voxel=0.0768 mm
3. The co-ordi-
nates of the clusters were reported according to the conventional
Lambda-Bregma system in the Allen Mouse Atlas (http://mouse.
brain-map.org/atlas/index.html).
In order to validate the segmentation reliability (i.e. to ensure that
the VBM result was not driven by misclassifications), regions of left
and right lateral ventricles from the automatic procedure were
extracted and compared to the manual ROI. The DICE similarity
co-efficient [98] was calculated to assess the degree of overlap
between manually defined ventricles and ventricles segmentedusing
the VBM routine where: DICE=2 ( ROI ventricles and VBM
ventricles)/(ROI ventricles or VBM ventricles).
The lowest DICE co-efficient between VBM and ROI ventricle
measurements was 0.92, and the mean DICE co-efficient between
VBM and ROI ventricle measurements was 0.927 for left lateral
ventricle and 0.948 for right lateral ventricle indicating substantial
overlap between the 2 techniques as shown in Figure 1.
Behavioral phenotyping
Subsequent to the MRI investigations we were interested to
confirm the differential impact of early and late MIA on
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disorders. We assessed the effects of prenatal immune challenge in
early (GD9) or late (GD17) gestation, relative to prenatal control
treatment, on sensorimotor gating using PPI of the acoustic startle
reflex. PPI impairment has been linked to several neuropsychiatric
disorders with a presumed neurodevelopmental origin, including
schizophrenia [75,99,100] and autism [80,81]. All the animals
included in the MRI analysis were tested 1 week after MRI
scanning. To rule out any unpredictable effect of MRI on
behaviour we extended the sample to include a scan naı ¨ve sample
prenatally exposed to saline or polyI:C. Behavioral testing was
conducted during the dark phase of the light-dark cycle.
Prepulse inhibition (PPI) of the acoustic startle
reflex. The procedures and testing parameters for evaluation of
PPI essentially followed those described previously [101]. In order to
exclude the effect of MRI scan on PPI test, we initially compared PPI
in a group of mice exposed to saline or polyI:C without MRI scan
with groups tested after MRI scan. The results showed no significant
effect of scan on PPI in any group (data not shown) therefore mice
with and without scan were combined. Final numbers in the PPI
experiment were: controls=18 (8 with MRI scan, 10 without scan),
GD9 PolyIC=13 (8 with scan, 5 without scan) and GD 17
PolyIC=17 (6 with scan, 11 without scan). Two standard acoustic
startle chambers for mice (SR-LAB, San Diego Instruments, San
Diego, CA, USA) generated the continuous background noise of
65 dBA and white noise stimuli. Whole body response was
transformed to an analogue signal by a piezoelectric unit then
digitized and stored. At the onset of the pulse (for pulse alone or
prepulse-pulse trials) or prepulse (for prepulse alone trials) 130
readings were taken at 0.5-ms intervals (across 65 ms) and the
average amplitude (in arbitrary units) over 65 ms indicated reactivity
to the pulse or prepulse stimuli. In a test session lasting approximately
45 min a mixture of pulse-alone, prepulse-plus-pulse, prepulse-alone
and no-stimulus (background noise) trials were presented. PPI was
calculated as the reduction of startle responses in the prepulse-plus-
pulse trials relative to startle in pulse-alone trials. Pulse stimuli were
100, 110, and 120 dBA lasting 40 ms. Prepulse stimuli were 20 ms
duration of 6, 12, and 18 dBA units above background respectively
with 100 ms stimulus onset asynchrony between prepulse and pulse
stimuli on prepulse-plus-pulse trials. Animals were acclimatized for
2 min priorto the first trial.Thefirst 6trialswere2 pulse onlytrialsof
each of the 3 pulse intensities to stabilize the startle response. Then
followed 10 blocks of 16 trials in pseudorandom order, each block
comprising: 3 pulse-alone trials (100, 110 or 120 dBA), 3 prepulse-
alone trials (+6, +12, or +18 dBA units above background), 9
combinations of prepulse-plus-pulse trials(3prepulse options63 pulse
options), and 1 no-stimulus trial (ns), with a variable intertrial interval
of a mean of 15 s (10 s to 20 s). The session ended with a final block
of 6 pulse-alone trials as in the first block.
Statistical analysis
Behavioral test data was analyzed using parametric analysis of
variance(ANOVA)and analysisof covariance(ANCOVA),followed
by post-hoc Scheffe test if appropriate. Where data was not normally
distributed, the values were transformed or non-parametric testing
adopted. The criterion for statistical significance was set as p,0.05.
All analyses were conducted using the statistical software SPSS for
Windows (version 16). Behavioral and MRI indices from offspring
prenatally exposed to control saline treatment at GD9 and GD17
were not different, therefore they were combined to form a single
control group. One animal (a GD9 control which failed to thrive
postnatally) was excluded from the analyses.
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